Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash from Financing Activities (2017 - 2025)

Inspire Medical Systems' Cash from Financing Activities history spans 9 years, with the latest figure at -$48.3 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 31.12% year-over-year to -$48.3 million; the TTM value through Dec 2025 reached -$183.4 million, down 250.14%, while the annual FY2025 figure was -$183.4 million, 250.14% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$48.3 million at Inspire Medical Systems, up from -$51.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $224.1 million in Q3 2022 and bottomed at -$87.8 million in Q1 2025.
  • The 5-year median for Cash from Financing Activities is $3.5 million (2021), against an average of $1.4 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 5732.03% in 2022 before it plummeted 11527.08% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $4.1 million in 2021, then surged by 78.83% to $7.3 million in 2022, then crashed by 238.77% to -$10.1 million in 2023, then crashed by 593.41% to -$70.1 million in 2024, then skyrocketed by 31.12% to -$48.3 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Cash from Financing Activities are -$48.3 million (Q4 2025), -$51.1 million (Q3 2025), and $3.7 million (Q2 2025).